HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.

Abstract
alpha-Galactosylceramide (alpha-GalCer) is a specific ligand of natural killer T cells (NKT cells) that regulates the immune responses such as tumor rejection and autoimmunity by producing interferon (IFN)-gamma and interleukin (IL)-4. However, it has not been determined whether alpha-GalCer-activated NKT cells modulate allergic inflammation. Because alpha-GalCer induces a large amount of IFN-gamma production by NKT cells, we hypothesized that an in vivo administration of alpha-GalCer could inhibit allergic airway inflammation in mice. Strikingly, a single intraperitoneal injection of alpha-GalCer almost completely abrogated an infiltrate with eosinophils in the lung tissue as well as in the bronchoalveolar lavage. This inhibition of allergic inflammation was associated with a significant decrease in the levels of IL-4, IL-5, and IL-13 in bronchoalveolar lavage fluid and in the number of goblet cells. In addition, this ligand significantly inhibited airway hyperresponsiveness to inhaled methacholine and raised the serum levels of ovalbumin-specific IgG2a with a decrease in those of ovalbumin-specific IgE. In IFN-gamma knockout mice, however, alpha-GalCer failed to exert such inhibitory effects in this asthma model. These results indicate that alpha-GalCer prevents allergic airway inflammation possibly through IFN-gamma production by ligand-activated NKT cells, suggesting the potential therapeutic application of alpha-GalCer in asthma.
AuthorsHiroyuki Matsuda, Takafumi Suda, Jun Sato, Toshi Nagata, Yukio Koide, Kingo Chida, Hirotoshi Nakamura
JournalAmerican journal of respiratory cell and molecular biology (Am J Respir Cell Mol Biol) Vol. 33 Issue 1 Pg. 22-31 (Jul 2005) ISSN: 1044-1549 [Print] United States
PMID15802553 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens
  • Galactosylceramides
  • Immunoglobulin G
  • Ligands
  • alpha-galactosylceramide
  • Immunoglobulin E
  • Interferon-gamma
  • Ovalbumin
Topics
  • Animals
  • Antigens (chemistry)
  • Asthma (pathology)
  • Bronchoalveolar Lavage Fluid
  • Cytotoxicity, Immunologic (immunology)
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Galactosylceramides (physiology)
  • Goblet Cells (pathology)
  • Hyperplasia
  • Hypersensitivity
  • Immunoglobulin E (metabolism)
  • Immunoglobulin G (immunology)
  • Inflammation
  • Interferon-gamma (genetics, metabolism)
  • Killer Cells, Natural (cytology)
  • Ligands
  • Lung (pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Ovalbumin (metabolism)
  • T-Lymphocytes (cytology)
  • Th2 Cells
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: